Osaic Holdings
MED icon

Osaic Holdings’s Medifast MED Stock Holding History

Osaic Holdings’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.5K Hold
1,370
– – ﹤0.01% 6390
2026
Q1 		$14K Sell
1,370
-2
-0.1% -$22 ﹤0.01% 6098
2025
Q4 		$14.7K Sell
1,372
-50
-4% -$598 ﹤0.01% 6074
2025
Q3 		$19.5K Buy
1,422
+50
+4% +$698 ﹤0.01% 5944
2025
Q2 		$19.3K Buy
1,372
+1,173
+589% +$15.4K ﹤0.01% 5734
2025
Q1 		$2.68K Sell
199
-25
-11% -$375 ﹤0.01% 6480
2024
Q4 		$3.95K Sell
224
-414
-65% -$7.68K ﹤0.01% 6313
2024
Q3 		$12.2K Sell
638
-1,055
-62% -$20.3K ﹤0.01% 5690
2024
Q2 		$36.9K Sell
1,693
-340
-17% -$9.06K ﹤0.01% 4916
2024
Q1 		$77.9K Buy
2,033
+572
+39% +$27.7K ﹤0.01% 4416
2023
Q4 		$98.2K Sell
1,461
-549
-27% -$38.2K ﹤0.01% 4456
2023
Q3 		$150K Sell
2,010
-1,267
-39% -$112K ﹤0.01% 4207
2023
Q2 		$302K Sell
3,277
-667
-17% -$59.4K ﹤0.01% 3574
2023
Q1 		$407K Buy
3,944
+1,826
+86% +$202K ﹤0.01% 3268
2022
Q4 		$244K Buy
2,118
+595
+39% +$69.3K ﹤0.01% 3678
2022
Q3 		$164K Sell
1,523
-187
-11% -$26.8K ﹤0.01% 3939
2022
Q2 		$309K Sell
1,710
-160
-9% -$28.6K ﹤0.01% 3396
2022
Q1 		$282K Buy
1,870
+28
+2% +$5.28K ﹤0.01% 3734
2021
Q4 		$385K Sell
1,842
-1,593
-46% -$329K ﹤0.01% 3321
2021
Q3 		$662K Buy
3,435
+804
+31% +$198K ﹤0.01% 2739
2021
Q2 		$746K Buy
2,631
+106
+4% +$28.7K ﹤0.01% 2608
2021
Q1 		$537K Buy
2,525
+143
+6% +$34.2K ﹤0.01% 2798
2020
Q4 		$467K Buy
2,382
+101
+4% +$17.8K ﹤0.01% 2711
2020
Q3 		$372K Sell
2,281
-235
-9% -$38.7K ﹤0.01% 2706
2020
Q2 		$350K Buy
2,516
+907
+56% +$83.3K ﹤0.01% 2648
2020
Q1 		$102K Buy
+1,609
New +$146K ﹤0.01% 3458

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCP
Steamboat Capital Partners Rye, New York $468M AUM 80.81% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Osaic Holdings's MED Position: Q2 2026 in Review

Osaic Holdings held its Medifast (MED) position steady in Q2 2026 at 1,370 shares worth $14.5K. The position accounts for ﹤0.01% of the portfolio, ranked #6390.

Osaic Holdings first reported a position in MED in Q1 2020 and has held it in 26 quarters since. The position peaked at $746K in Q2 2021. 113 funds tracked by Wall St. Rank hold MED as of Q2 2026.

  • Osaic Holdings held 1,370 shares of Medifast worth $14.5K as of Q2 2026.
  • Osaic Holdings left its Medifast share count unchanged in Q2 2026.
  • Medifast made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6390 holding.
  • Osaic Holdings first reported a position in Medifast in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Medifast position peaked at $746K in Q2 2021.
  • 113 funds tracked by Wall St. Rank held Medifast as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.